Class II

Drug Recall: Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeto

Aurobindo Pharma USA Inc. · April 24, 2024

Reason for Recall

Discoloration: Dotted and yellow spots on tablets

Product Description

Clorazepate Dipotassium Tablets, USP, 7.5 mg, a) 100 tablets per bottle, NDC 13107-283-01, b) 500 tablets per bottle, NDC 13107-283-05, Rx Only, Distributed by Aurobindo Pharma USA, Inc., 279 Princeton-Hightstown Road, East Windsor, NJ 08520, Made in India.

Distribution

Nationwide in the USA

States Affected

NATIONWIDE

Quantity Affected

6909 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0492-2024

Status: ongoing

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.